SPARQL | HTML5 RDFa and Microdata document
https://identifiers.org/ncbigene/9252
https://identifiers.org/ensembl/ENSG00000087245
https://identifiers.org/ensembl/ENSG00000100985
https://identifiers.org/ensembl/ENSG00000138798
https://identifiers.org/ncbigene/3576
https://identifiers.org/ncbigene/4609
https://identifiers.org/ncbigene/5296
https://identifiers.org/wikipathways/WP382
https://identifiers.org/ncbigene/1890
https://identifiers.org/ncbigene/7057
https://identifiers.org/ensembl/ENSG00000100373
https://identifiers.org/wikipathways/WP2828
https://identifiers.org/ncbigene/11186
https://identifiers.org/ncbigene/999
https://identifiers.org/pubmed/25514926
https://identifiers.org/wikipathways/WP1742
https://identifiers.org/wikipathways/WP673
https://identifiers.org/ensembl/ENSG00000068078
https://identifiers.org/ensembl/ENSG00000078061
https://identifiers.org/ensembl/ENSG00000100030
https://identifiers.org/ensembl/ENSG00000113070
https://identifiers.org/ensembl/ENSG00000126934
https://identifiers.org/ensembl/ENSG00000132155
https://identifiers.org/ensembl/ENSG00000133703
https://identifiers.org/ensembl/ENSG00000169032
https://identifiers.org/ensembl/ENSG00000197122
https://identifiers.org/ensembl/ENSG00000213281
https://identifiers.org/ncbigene/1019
https://identifiers.org/ncbigene/1026
https://identifiers.org/ncbigene/1029
https://identifiers.org/ncbigene/1869
https://identifiers.org/ncbigene/1956
https://identifiers.org/ncbigene/2064
https://identifiers.org/ncbigene/3265
https://identifiers.org/ncbigene/4193
https://identifiers.org/ncbigene/4312
https://identifiers.org/ncbigene/5295
https://identifiers.org/ncbigene/5925
https://identifiers.org/ncbigene/595
https://identifiers.org/ncbigene/673
https://identifiers.org/ncbigene/7157
https://identifiers.org/ncbigene/7422
https://identifiers.org/wikipathways/WP1539
https://identifiers.org/wikipathways/WP179
https://identifiers.org/ncbigene/1612
https://identifiers.org/ncbigene/1613
https://identifiers.org/ncbigene/23604
https://identifiers.org/wikipathways/WP1919
http://rdf.wikipathways.org/Pathway/WP2828_r137131/WP/Interaction/b1b1e
http://rdf.wikipathways.org/Pathway/WP2828_r137131/WP/Interaction/f1dea
http://rdf.wikipathways.org/Pathway/WP2828_r137131/WP/Interaction/id32f08084
http://rdf.wikipathways.org/Pathway/WP2828_r137131/WP/Interaction/id381e49fa
http://rdf.wikipathways.org/Pathway/WP2828_r137131/WP/Interaction/id485f7ae4
http://rdf.wikipathways.org/Pathway/WP2828_r137131/WP/Interaction/id4ba68714
http://rdf.wikipathways.org/Pathway/WP2828_r137131/WP/Interaction/id56c10b86
http://rdf.wikipathways.org/Pathway/WP2828_r137131/WP/Interaction/id573d64ea
http://rdf.wikipathways.org/Pathway/WP2828_r137131/WP/Interaction/id5f2cd806
http://rdf.wikipathways.org/Pathway/WP2828_r137131/WP/Interaction/id689a30f6
http://rdf.wikipathways.org/Pathway/WP2828_r137131/WP/Interaction/id744f335d
http://rdf.wikipathways.org/Pathway/WP2828_r137131/WP/Interaction/id95aba50d
http://rdf.wikipathways.org/Pathway/WP2828_r137131/WP/Interaction/id9c6d4e0b
http://rdf.wikipathways.org/Pathway/WP2828_r137131/WP/Interaction/idc16d11bb
http://rdf.wikipathways.org/Pathway/WP2828_r137131/WP/Interaction/idccf02e8e
https://identifiers.org/wikipathways/WP2828_r137131
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/2004/02/skos/core#Collection
http://vocabularies.wikipathways.org/wp#Pathway
http://vocabularies.wikipathways.org/wp#cellTypeOntologyTag
http://purl.obolibrary.org/obo/CL_1001428
http://vocabularies.wikipathways.org/wp#diseaseOntologyTag
http://purl.obolibrary.org/obo/DOID_365
http://purl.obolibrary.org/obo/DOID_162
http://purl.obolibrary.org/obo/DOID_4465
http://purl.obolibrary.org/obo/DOID_11054
http://vocabularies.wikipathways.org/wp#isAbout
http://rdf.wikipathways.org/Pathway/WP2828_r137131
http://vocabularies.wikipathways.org/wp#ontologyTag
http://purl.obolibrary.org/obo/PW_0000013
http://purl.obolibrary.org/obo/PW_0000605
http://vocabularies.wikipathways.org/wp#Curation:AnalysisCollection
http://purl.obolibrary.org/obo/DOID_365
http://purl.obolibrary.org/obo/CL_1001428
http://vocabularies.wikipathways.org/wp#Curation:CPTAC
http://vocabularies.wikipathways.org/wp#Curation:Diseases
http://purl.obolibrary.org/obo/DOID_162
http://purl.obolibrary.org/obo/DOID_4465
http://purl.obolibrary.org/obo/DOID_11054
http://vocabularies.wikipathways.org/wp#organism
http://purl.obolibrary.org/obo/NCBITaxon_9606
http://vocabularies.wikipathways.org/wp#organismName
http://vocabularies.wikipathways.org/wp#pathwayOntologyTag
http://purl.obolibrary.org/obo/PW_0000013
http://purl.obolibrary.org/obo/PW_0000605
http://xmlns.com/foaf/0.1/img
https://www.wikipathways.org//wpi/wpi.php?action=downloadFile&type=svg&pwTitle=Pathway:WP2828&oldid=137131
https://www.wikipathways.org//wpi/wpi.php?action=downloadFile&type=png&pwTitle=Pathway:WP2828&oldid=137131
http://xmlns.com/foaf/0.1/page
http://www.wikipathways.org/instance/WP2828_r137131
http://purl.org/dc/elements/1.1/identifier
https://identifiers.org/wikipathways/WP2828
http://purl.org/dc/elements/1.1/source
http://purl.org/dc/elements/1.1/title
http://purl.org/dc/terms/description
The urothelium covers the luminal surface of almost the entire urinary tract, extending from the renal pelvis, through the ureter and bladder, to the proximal urethra. The majority of urothelial carcinomas are bladder carcinomas, and urothelial carcinomas of the renal pelvis and ureter account for only approximately 7% of the total. Urothelial tumors arise and evolve through divergent phenotypic pathways. Some tumors progress from urothelial hyperplasia to low-grade non-invasive superficial papillary tumors. More aggressive variants arise either from flat, high-grade carcinoma in situ (CIS) and progress to invasive tumors, or they arise de novo as invasive tumors. Low-grade papillary tumors frequently show a constitutive activation of the receptor tyrosine kinase-Ras pathway, exhibiting activating mutations in the HRAS and fibroblast growth factor receptor 3 (FGFR3) genes. In contrast, CIS and invasive tumors frequently show alterations in the TP53 and RB genes and pathways. Invasion and metastases are promoted by several factors that alter the tumor microenvironment, including the aberrant expression of E-cadherins (E-cad), matrix metalloproteinases (MMPs), angiogenic factors such as vascular endothelial growth factor (VEGF). Phosphorylation sites were added based on information from PhosphoSitePlus (R), https://www.phosphosite.org.
Proteins on this pathway have targeted assays available via the [CPTAC Assay Portal](https://assays.cancer.gov/available_assays?wp_id=WP2828).
http://purl.org/dc/terms/identifier
http://purl.org/dc/terms/references
https://identifiers.org/pubmed/25514926
http://purl.org/spar/cito/cites
https://identifiers.org/pubmed/16474624
https://identifiers.org/pubmed/22417847
https://identifiers.org/pubmed/22899908
https://identifiers.org/pubmed/25514926
https://identifiers.org/pubmed/23175443